Evidence map›Paper›PMID 40782283›Full record

ReviewMedical oncology (Northwood, London, England)2025

A comprehensive review on the role of plant-derived bioactive metabolites driving ROS-mediated apoptosis in cancer.

Canivizhi Vidjeyamannane, Alan Joy, Kishore Prakash, Rupachandra Saravanakumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Canivizhi VidjeyamannaneDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
Alan JoyDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
Kishore PrakashDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India.
Rupachandra SaravanakumarDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603 203, India. rupachas@srmist.edu.in.ORCID http://orcid.org/0000-0001-5140-5989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive Oxygen Species (ROS) are essential in inducing cancer cell death through the promotion of oxidative stress, DNA damage, and the disturbance of cellular homeostasis. Natural bioactive chemicals sourced from plants and other natural products are significant for their capacity to selectively regulate ROS levels and cause apoptosis in cancer cells while sparing normal cells. The study gives a thorough summary of the molecular mechanisms of ROS-induced apoptosis, including mitochondrial damage, pro-apoptotic pathway activation, and inhibition of anti-apoptotic proteins. The review focuses on several natural bioactive molecules, such as polyphenols, flavonoids, alkaloids, and terpenoids that have anticancer activity through ROS induction. The potential therapeutic application of the compounds in increasing the effectiveness of standard cancer therapies and reducing drug resistance is likewise discussed. In addition, the review discusses the challenge of clinical translation of these bioactive compounds with respect to bioavailability, stability, and site-specific delivery. In conclusion, this review highlights the promising potential of ROS-modulating bioactive compounds as a new therapeutic strategy for cancer treatment, with insights into their mechanistic action and therapeutic implications.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisNeoplasmsReactive Oxygen SpeciesAnimalsHumansOxidative StressAntineoplastic Agents, PhytogenicReactive Oxygen SpeciesApoptosisCancer therapyNatural bioactive compoundsOxidative stressROS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.